I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
A potential novel cancer immunotherapy: Agonistic anti-CD40..:
Jian, Cheng-Zhe
;
Lin, Li
;
Hsu, Chia-Lang
...
Drug Discovery Today. 29 (2024) 3 - p. 103893 , 2024
Link:
https://doi.org/10.1016/j.drudis.2024.103893
RT Journal T1
A potential novel cancer immunotherapy: Agonistic anti-CD40 antibodies
UL https://suche.suub.uni-bremen.de/peid=cr-10.1016_j.drudis.2024.103893&Exemplar=1&LAN=DE A1 Jian, Cheng-Zhe A1 Lin, Li A1 Hsu, Chia-Lang A1 Chen, Yu-Hsin A1 Hsu, Chiun A1 Tan, Ching-Ting A1 Ou, Da-Liang PB Elsevier BV YR 2024 SN 1359-6446 JF Drug Discovery Today VO 29 IS 3 SP 103893 LK http://dx.doi.org/https://doi.org/10.1016/j.drudis.2024.103893 DO https://doi.org/10.1016/j.drudis.2024.103893 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)